Delivery Order 36F79720D0104-36C26124N0527

Award Date 3/20/24
Potential Completion Date 4/20/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The $88,161.72 order is for the supply of Tyvaso (treprostinil) inhalation solution, a medication used to treat pulmonary arterial hypertension. The contract is a task order placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs...
This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corporation, a self-certified small disadvantaged business and for-profit manufacturer of pharmaceutical goods. The $89,934.06 firm-fixed-price contract is for the bulk order of Tyvaso, an inhalation solution used to treat pulmonary arterial hypertension. The contract is issued against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs, which...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) to United Therapeutics Corp, a manufacturer of pharmaceutical goods. The contract, valued at $14,693.62, is for the supply of Tyvaso inhalation solution and related products to the VA's Veterans Integrated Service Network 21. United Therapeutics holds two national indefinite delivery/indefinite quantity (IDIQ) contracts with the VA, one valued at $50 million and the other at $198 million, which provide a...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to United Therapeutics Corp., a small disadvantaged business manufacturer, for $62,596.44. The order is for the drug Tyvaso inhalation solution and related products under the VA's GSA Pharmaceuticals and Drugs schedule contract. United Therapeutics has received over 50 prime contract awards from the VA through this schedule since 2020, providing pulmonary arterial...
This is a firm fixed price delivery order issued by the Department of Veterans Affairs (VA) Veterans Health Administration to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The $119,488.30 award is for the VA's procurement of the pulmonary arterial hypertension drug Tyvaso and associated inhalation solution starter/refill kits. This order was placed against United Therapeutics' pre-competed Federal Supply Schedule (FSS)...
This is a firm fixed price delivery order for $116,132.06 awarded by the Department of Veterans Affairs Veterans Health Administration to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The order was placed against United Therapeutics' pre-competed Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract supports the VA's distribution of pulmonary arterial hypertension and cancer treatments,...
This is a firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The contract, valued at $31,085.18, is for the supply of Tyvaso (treprostinil) inhalation solution, a medication used to treat pulmonary arterial hypertension. The contract is a delivery order placed against United Therapeutics' Federal Supply Schedule (FSS) contract for...
This is a delivery order for $16,391.56 awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corporation, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The order is for the drug Tyvaso (treprostinil) inhalation solution, a treatment for pulmonary arterial hypertension. The contract is issued under United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) with the VA. United...
This firm-fixed-price delivery order, valued at $16,031.60, was awarded to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods, by the U.S. Department of Veterans Affairs (VA). The order is for the TYVASO 64 MCG KIT, a pulmonary arterial hypertension treatment, and was placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. United Therapeutics is a biotechnology company that specializes...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The $14,693.62 award is for the supply of the TYVASO 0.6 REFILL KIT, a medication used to treat pulmonary arterial hypertension. The contract was placed against United Therapeutics' pre-competed Federal Supply Schedule (FSS) contract for Pharmaceuticals and...

This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) to United Therapeutics Corp, a small disadvantaged business and manufacturer of pharmaceutical products. The $14,693.62 contract is for the delivery of Tyvaso 0.6MG/ML, an inhalation solution used to treat pulmonary arterial hypertension, to VA medical facilities in Silver Spring, MD. The order was placed against United Therapeutics' pre-competed Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). United Therapeutics has received over 50 similar VA delivery orders since 2020, totaling up to $250 million through two national Indefinite Delivery, Indefinite Quantity (IDIQ) contracts. These IDIQ vehicles allow the VA to centrally source United Therapeutics' specialty pharmaceutical portfolio to support distribution of targeted therapies for veterans nationwide.

Generated 3/21/24, 10:43 AM